ME Therapeutics Holdings Inc. (CSE:METX)

ME Therapeutics Holdings Balance Sheet

Financials in millions CAD. Fiscal year is September - August.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Feb 28, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022
Cash & Equivalents	2	1.5	0.65	0.08
Cash & Short-Term Investments	2	1.5	0.65	0.08
Cash Growth	48.32%	131.28%	736.35%	-
Other Receivables	0.02	0.02	0.01	0.02
Receivables	0.02	0.02	0.01	0.02
Prepaid Expenses	0.06	0.03	0.02	0
Total Current Assets	2.08	1.54	0.67	0.1
Property, Plant & Equipment	0.25	0	0	0
Other Intangible Assets	0	0	0	0
Total Assets	2.34	1.54	0.67	0.1
Accounts Payable	0.01	0.05	0.11	0.02
Short-Term Debt	-	-	-	0.13
Current Portion of Long-Term Debt	-	-	0.04	-
Other Current Liabilities	-	0.02	0	0.02
Total Current Liabilities	0.1	0.06	0.15	0.17
Long-Term Debt	-	-	-	0.06
Total Liabilities	0.15	0.06	0.15	0.23
Common Stock	8.59	6.11	4.52	0.51
Retained Earnings	-9.04	-8.54	-7.24	-0.72
Comprehensive Income & Other	2.64	3.9	3.24	0.08
Shareholders' Equity	2.19	1.48	0.52	-0.13
Total Liabilities & Equity	2.34	1.54	0.67	0.1
Total Debt	0.1	-	0.04	0.19
Net Cash (Debt)	1.9	1.5	0.61	-0.12
Net Cash Growth	41.03%	146.52%	-	-
Net Cash Per Share	0.07	0.06	0.04	-0.01
Filing Date Shares Outstanding	26.19	25.19	23.56	15.7
Total Common Shares Outstanding	29.59	25.19	23.56	15.7
Working Capital	1.98	1.48	0.52	-0.07
Book Value Per Share	0.07	0.06	0.02	-0.01
Tangible Book Value	2.19	1.48	0.52	-0.13
Tangible Book Value Per Share	0.07	0.06	0.02	-0.01
Machinery	0.14	0	0	0

Updated Jan 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.